Home/Filings/4/A/0000899243-21-012710
4/A//SEC Filing

Sperzel John J III 4/A

Accession 0000899243-21-012710

CIK 0001492674other

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 9:44 AM ET

Size

5.6 KB

Accession

0000899243-21-012710

Insider Transaction Report

Form 4/AAmended
Period: 2021-02-24
Sperzel John J III
DirectorSee Remarks
Transactions
  • Award

    Restricted Stock Units

    2021-02-24+1,000,0001,000,000 total
    Common Stock (1,000,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]The restricted stock units vest in three equal annual installments commencing on February 24, 2022.

Issuer

T2 Biosystems, Inc.

CIK 0001492674

Entity typeother

Related Parties

1
  • filerCIK 0001602618

Filing Metadata

Form type
4/A
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 9:44 AM ET
Size
5.6 KB